Certified by Founder Lodge
Coave Therapeutics
France - PARIS
START UP
1 Disclosed Funding Rounds $32,000,000
0 Participating Investments
-
Founded date
2014
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases.
We are pushing the
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 09 ,2025 | Series A | $32,000,000 |
Omnes
UI Investissement
Turenne Groupe
Kurma Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
IntelliGRC | $3,500,000 | (Mar 6, 2026)
Cyclops | $8,000,000 | (Mar 6, 2026)
NextWork | $4,450,000 | (Mar 6, 2026)
Reclaim Security | $20,000,000 | (Mar 6, 2026)
Navigara | $2,500,000 | (Mar 6, 2026)
